Cargando…
Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo
Small interfering RNA (siRNA)-based therapies are proving to be efficient for treating liver-associated disorders. However, extra-hepatic delivery remains challenging, limiting therapeutic siRNA utility. We synthesized a panel of fifteen lipid-conjugated siRNAs and systematically evaluated the impac...
Autores principales: | Biscans, Annabelle, Coles, Andrew, Haraszti, Reka, Echeverria, Dimas, Hassler, Matthew, Osborn, Maire, Khvorova, Anastasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379722/ https://www.ncbi.nlm.nih.gov/pubmed/30544191 http://dx.doi.org/10.1093/nar/gky1239 |
Ejemplares similares
-
Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways
por: Osborn, Maire F, et al.
Publicado: (2019) -
5΄-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo
por: Haraszti, Reka A., et al.
Publicado: (2017) -
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo
por: Hassler, Matthew R, et al.
Publicado: (2018) -
Guanabenz (Wytensin™) selectively enhances uptake and efficacy of hydrophobically modified siRNAs
por: Osborn, Maire F., et al.
Publicado: (2015) -
The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy
por: Biscans, Annabelle, et al.
Publicado: (2020)